<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00141583</url>
  </required_header>
  <id_info>
    <org_study_id>LREC 01.87.10</org_study_id>
    <nct_id>NCT00141583</nct_id>
  </id_info>
  <brief_title>The Renin-Angiotensin System in Essential Hypertension</brief_title>
  <official_title>The Renin-Angiotensin System in Essential Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St George's, University of London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St George's, University of London</source>
  <brief_summary>
    <textblock>
      Although ACE Inhibitors and Angiotensin Receptor Blockers are effective blood pressure
      lowering agents, the exact mechanisms by which these agents lower BP are still not fully
      understood. This study aims to compare the blood pressure and hormonal responses (plasma
      renin activity and aldosterone) to the ACE inhibitor enalapril and ARB candesartan in
      individuals with mild essential hypertension.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Insufficient accrual rate
  </why_stopped>
  <start_date>April 2004</start_date>
  <completion_date type="Actual">October 2006</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in BP</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in PRA and aldosterone</measure>
  </primary_outcome>
  <enrollment type="Anticipated">11</enrollment>
  <condition>Hypertension</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Enalapril 20 mg bd</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Candesartan 8 mg bd</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Essential Hypertension

          -  SBP 140-159 mmHg

          -  DBP 90-99 mmHg

        Exclusion Criteria:

          -  Intolerance of or allergy to ACE Inhibitors or ARBS

          -  Pregnant or Breastfeeding

          -  Pre-menopausal women

          -  Uncontrolled cardiac or renal failure

          -  Diabetes mellitus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy WR Doulton, BSc MRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>SGUL</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Blood Pressure Unit, Dept. Cardiac &amp; Vascular Sciences, SGUL</name>
      <address>
        <city>London</city>
        <zip>SW17 0RE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 31, 2005</study_first_submitted>
  <study_first_submitted_qc>August 31, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2005</study_first_posted>
  <last_update_submitted>June 5, 2015</last_update_submitted>
  <last_update_submitted_qc>June 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 9, 2015</last_update_posted>
  <keyword>Renin-angiotensin system</keyword>
  <keyword>ACE Inhibitor</keyword>
  <keyword>Angiotensin Receptor Blocker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Candesartan</mesh_term>
    <mesh_term>Enalapril</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

